Allspring Cuts Docusign Stake 54%, Sells $2.42M in Shares
Allspring Global Investments Holdings LLC reduced its Docusign position by 54% in Q3, selling 41,270 shares and holding 35,112 shares valued at $2.42M. Separately, insiders sold 45,542 shares worth $3.09M, highlighting increased selling pressure from both institutional and executive stakeholders.
1. Allspring Global Investments Significantly Reduces Stake
In the third quarter, Allspring Global Investments Holdings LLC slashed its position in Docusign by 54%, selling 41,270 shares and ending the period with 35,112 shares. This reduction represented a withdrawal of roughly 2.4 million in market value at quarter-end, down from the prior level of holdings. The disposals mark one of the largest single-quarter stake reductions among institutional investors in Docusign this year, suggesting a reassessment of the company’s near-term growth prospects by Allspring’s portfolio managers.
2. Other Institutional Moves Highlight Divergent Views
Several smaller advisory firms and hedge funds have taken opposite approaches. Twin Peaks Wealth Advisors initiated a position in the second quarter with approximately 700 shares, while MassMutual Private Wealth & Trust FSB boosted its holdings by 31.3%, ending the period with nearly 600 shares. First Horizon Advisors increased its stake by 48.6% to just under 600 shares, and Hantz Financial Services more than doubled its exposure, adding 437 shares for a total of 848. New money also arrived from Sumitomo Mitsui Financial Group, which opened a position in the second quarter. Overall, institutional ownership stands at roughly 78%, indicating continued strategic interest despite recent sell-downs.
3. Analyst Ratings Reflect Cautious Consensus
Following a string of price-target cuts by Wells Fargo, Piper Sandler and UBS to a common level of seventy-five, six analysts maintain Buy verdicts on Docusign while sixteen recommend Hold. Zacks Research downgraded its view from Strong Buy to Hold, and Weiss Ratings reaffirmed a Hold classification. The consensus target sits near eighty-five, implying limited upside from current valuations. Docusign’s price-to-earnings multiple remains elevated relative to its historical average, and its beta of nearly one underscores a stock performance closely tracking broader market swings.
4. Insider Sales Weigh on Sentiment
Corporate insiders have collectively sold 45,542 shares over the last quarter, representing a 1% reduction in total insider ownership. Notable transactions include a director’s sale of 450 shares and the chief revenue officer’s sale of 6,000 shares, each representing around 3% and 8% declines in their respective holdings. These disposals, disclosed in SEC filings during December and early January, have generated scrutiny from investors who watch insider behavior for signals about internal confidence in the company’s growth trajectory.